Macrophage-Specific NLRC5 Protects From Cardiac Remodeling Through Interaction With HSPA8

Qing Yu,Peinan Ju,Wenxin Kou,Ming Zhai,Yanxi Zeng,Nuerbiyemu Maimaitiaili,Yefei Shi,Xu Xu,Yifan Zhao,Weixia Jian,Mark W. Feinberg,Yawei Xu,Jianhui Zhuang,Wenhui Peng
DOI: https://doi.org/10.1016/j.jacbts.2022.10.001
2023-01-20
Abstract:Summary Macrophages regulate inflammation and the process of tissue repair. Therefore, a better understanding of macrophages in the pathogenesis of heart failure is needed. In patients with hypertrophic cardiomyopathy, NLRC5 was significantly increased in circulating monocytes and cardiac macrophages. Myeloid-specific deletion of NLRC5 aggravated pressure overload–induced pathological cardiac remodeling and inflammation. Mechanistically, NLRC5 interacted with HSPA8 and suppressed NF-κB pathway in macrophages. The absence of NLRC5 in macrophages promoted the secretion of cytokines such as interleukin-6 (IL-6), which affected cardiomyocyte hypertrophy and cardiac fibroblast activation. Tocilizumab, an anti–IL-6 receptor antagonist, may be a novel therapeutic strategy for cardiac remodeling and chronic heart failure.
cardiac & cardiovascular systems
What problem does this paper attempt to address?